AMIDES OF ANTIBIOTIC STREPTONIGRIN AND AMINO DICARBOXYLIC ACIDS OR AMINOSUGARS SYNTHESIS AND BIOLOGICAL EVALUATION
Sir:
Streptonigrin has been shown to be a potent cytotoxic agent, with broad spectrum activity in a number of murine tumor models1\ Recently it was shown that streptonigrin is a nonintercalative antibiotic, which induces mammaliantopoisomerase II dependent DNAcleavage2). It is a strong inhibitor of the reverse transcriptase associated with avian myeloblastosis virus and humanimmunodeficiency virus3). However, the severe side effects of streptonigrin, mainly bone marrow depression, have resulted in the discontinuation of its clinical use as an antitumor compound.
Here we report on the preparation and biological evaluation of the amides of streptonigrin and amino dicarboxylic acids or aminosugars, which may be of interest, as they should be more water-soluble and possibly less toxic.
In the synthesis of streptonigrin amides we used the iV-hydroxysuccinimide ester of streptonigrin (2), which represents a convenient agent for the preparation of poly functional derivatives as in this case there is no need to protect hydroxy groups of aminosugars. Streptonigrin (1) and iV-hydroxysuccinimide in THFin the presence of DCCprovided 2 (Tables 1  and 2 ). 2 was purified by column chromatography JUNE 1992 on Sephadex LH-20 using chloroform-methanol 
The amides of streptonigrin and aminosugars (7~11) were obtained by the interaction of 2 with 2-amino-2-deoxy-D-glucose, 2-amino-2-deoxy-Dgalactose, 6-amino-D-fucose, methyl 2,6-dideoxy-6-amino-/?-D-glucopyranoside or Af-methyl-1 -deoxy-1-amino-D-glucitol in a 1 : 1 mixture of methanol with DMF(Scheme 2). After 72 hours the reaction mixture was evaporated in vacuo at 30°C and azeotroped with toluene (several times). The residue was purified by gel filtration on a Sephadex LH-20 column using chloroform -methanol (7 : 3) as eluant (Table  1) . Compound 2 did not interact with 2,3,4,6-tetra-O-acetyl-l-mercapto-D-galactose or 2,3,4,6-tetra-<9-benzoyl-/?-D-galactopyranosyl amine, whichsuggests that these mercaptoor amino groups do not possess the necessary nucleophilicity. The structures of amides 3, 4, 5 and 6 were confirmed by *H NMRand EI-MS. Previously we used a similar method for the preparation of amides of streptonigrin and anthracycline antibiotics daunorubicin, carminomycin or doxorubicin4), as well as for the amides of d-and l-CH3SCH2-SCH2CH(NH2)COOCH35). All these compounds The inhibitory effects of streptonigrin (1) and compounds5~11 on the proliferation of murine leukemia (LI210), human T-lymphoblast (MOLT-4F) and human T-lymphocyte (MT-4) cells are shown in Table 3 . The assays for measuring inhibition of tumor cell growth and HIV-1 cytopathicity in MT-4 cells were performed as previously described8'9). All new amides (5~11)
were markedly less cytostatic than 1. Interestingly, these amides were 50-to 100-fold more inhibitory to MT-4 than L1210 or MOLT-4F cell proliferation. In fact, the cytostatic data obtained for L1210
or MOLT-4F cells have been obtained upon RLV-containing serum was dissolved 1 : 10 in Hank's solution. Female BALB/cmice were inoculated intravenously (iv) with 0.2ml of the viral inoculum on day 0. Drugs were dissolved in 0.9% saline solution and administered daily (by the intraperitoneal (ip) route) starting 5 hours after virus inoculation and continuing for 7 days. All the mice were sacrificed on the 7th day after virus inoculation and were examined for body weight, spleen weight and number of colonies (on the spleen surface). DRD: drug related deaths. SD: standard deviation. a Statistically significant difference between treated and control groups. b In parentheses, %reduction in a spleen enlargement and the numberof colonies. In vivo antiviral activity against rausher leukemia virus (RLV) was monitored by mortality (until the 7-day period), change of body weight over the 7-day period, spleen weight, and spleen colony formation (Table 4) of all mice within 7 days. Amide ll brought about a significant reduction in spleen weight at doses of 12.5 and 200/zg/kg/day and a significant reduction in the number of colonies (on the spleen surface) at a dose of 50/zg/kg/day).
In contrast with 1, compound ll was non-toxic at a dose of 800 /ig/kg/day (Table 4) .
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